| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Clinical Officer
1 company
Slonin Jonathan is a Chief Medical Officer at Pacira BioSciences, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 3,960 | $24.09 | $95,396.40 | -2.2% | -4.8% | - | |
| Jan 6, 2025 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 879 | $18.40 | $16,173.60 | -0.9% | +23.0% | +35.9% | |
| Aug 2, 2024 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 945 | $20.05 | $18,947.25 | -1.0% | -21.9% | +3.8% | |
| Jul 2, 2024 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 2,836 | $28.25 | $80,117.00 | -2.9% | -33.8% | +2.1% | |
| Jun 11, 2024 | PCRX Pacira Biosciences, Inc. | Chief Medical Officer | Sell | 5,012 | $28.57 | $143,192.84 | -10.1% | -54.3% | -16.0% | |
| Jun 7, 2023 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sell | 961 | $38.42 | $36,918.61 | -1.3% | -7.4% | -22.4% | |
| Aug 3, 2022 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sell | 308 | $55.70 | $17,155.60 | -0.8% | -9.4% | -33.1% | |
| Jul 5, 2022 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sell | 924 | $57.19 | $52,841.71 | -2.4% | -5.6% | -33.5% | |
| Jun 6, 2022 | PCRX Pacira Biosciences, Inc. | Chief Clinical Officer | Sell | 362 | $61.37 | $22,217.39 | -1.3% | -15.5% | -35.6% |